Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Induction of Immune Response Against Metastatic Tumors via Vaccination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibody (MBTA).
Medina R, Wang H, Caisová V, Cui J, Indig IH, Uher O, Ye J, Nwankwo A, Sanchez V, Wu T, Nduom E, Heiss J, Gilbert MR, Terabe M, Ho W, Zenka J, Pacak K, Zhuang Z. Medina R, et al. Among authors: caisova v. Adv Ther (Weinh). 2020 Sep;3(9):2000044. doi: 10.1002/adtp.202000044. Epub 2020 Jun 9. Adv Ther (Weinh). 2020. PMID: 33709018 Free PMC article.
The use of anchored agonists of phagocytic receptors for cancer immunotherapy: B16-F10 murine melanoma model.
Janotová T, Jalovecká M, Auerová M, Švecová I, Bruzlová P, Maierová V, Kumžáková Z, Cunátová Š, Vlčková Z, Caisová V, Rozsypalová P, Lukáčová K, Vácová N, Wachtlová M, Salát J, Lieskovská J, Kopecký J, Ženka J. Janotová T, et al. Among authors: caisova v. PLoS One. 2014 Jan 13;9(1):e85222. doi: 10.1371/journal.pone.0085222. eCollection 2014. PLoS One. 2014. PMID: 24454822 Free PMC article.
The use of Zymosan A and bacteria anchored to tumor cells for effective cancer immunotherapy: B16-F10 murine melanoma model.
Waldmannová E, Caisová V, Fáberová J, Sváčková P, Kovářová M, Sváčková D, Kumžáková Z, Jačková A, Vácová N, Nedbalová P, Horká M, Kopecký J, Ženka J. Waldmannová E, et al. Among authors: caisova v. Int Immunopharmacol. 2016 Oct;39:295-306. doi: 10.1016/j.intimp.2016.08.004. Epub 2016 Aug 6. Int Immunopharmacol. 2016. PMID: 27505858
Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model.
Caisová V, Vieru A, Kumžáková Z, Glaserová S, Husníková H, Vácová N, Krejčová G, Paďouková L, Jochmanová I, Wolf KI, Chmelař J, Kopecký J, Ženka J. Caisová V, et al. BMC Cancer. 2016 Dec 7;16(1):940. doi: 10.1186/s12885-016-2982-x. BMC Cancer. 2016. PMID: 27927165 Free PMC article.
The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40.
Caisova V, Li L, Gupta G, Jochmanova I, Jha A, Uher O, Huynh TT, Miettinen M, Pang Y, Abunimer L, Niu G, Chen X, Ghayee HK, Taïeb D, Zhuang Z, Zenka J, Pacak K. Caisova V, et al. Cancers (Basel). 2019 May 11;11(5):654. doi: 10.3390/cancers11050654. Cancers (Basel). 2019. PMID: 31083581 Free PMC article.
17 results